ImmunoPrecise Antibodies (IPA) has released an update.
ImmunoPrecise Antibodies Ltd. has postponed the release of its full year fiscal 2024 financial results and business highlights, which will now be presented on July 29, 2024. This rescheduling is to provide additional time for auditors to finalize the valuation of goodwill and intangible assets, ensuring accurate financial reporting. An earnings conference call will accompany the release and will be accessible via a live webcast on the company’s Investor Relations website.
For further insights into IPA stock, check out TipRanks’ Stock Analysis page.
